The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-{3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-2-hydroxy-propoxy}-phenyl)-phenyl-methanone ID: ALA148318
PubChem CID: 10598951
Max Phase: Preclinical
Molecular Formula: C26H27FN2O3
Molecular Weight: 434.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccccc1)c1ccccc1OCC(O)CN1CCN(c2ccc(F)cc2)CC1
Standard InChI: InChI=1S/C26H27FN2O3/c27-21-10-12-22(13-11-21)29-16-14-28(15-17-29)18-23(30)19-32-25-9-5-4-8-24(25)26(31)20-6-2-1-3-7-20/h1-13,23,30H,14-19H2
Standard InChI Key: UHWBVAVSBQYTQW-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
3.2042 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2000 0.3375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7750 -0.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9125 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2042 -0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -1.7375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -0.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4875 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2000 -0.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0625 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6292 0.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9125 1.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7667 0.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4875 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3417 -0.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -0.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3417 1.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6250 1.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3417 0.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0542 1.9875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.4875 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3417 0.3333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4875 -0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2042 -3.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -3.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7750 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2042 -4.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6417 -4.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7750 -0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9250 -4.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 10 1 0
4 12 1 0
5 3 1 0
6 1 1 0
7 2 2 0
8 6 1 0
9 15 1 0
10 16 1 0
11 2 1 0
12 17 1 0
13 5 2 0
14 5 1 0
15 4 1 0
16 4 1 0
17 18 1 0
18 8 1 0
19 20 1 0
20 14 2 0
21 13 1 0
22 19 1 0
23 1 2 0
24 17 1 0
25 6 2 0
26 11 2 0
27 11 1 0
28 23 1 0
29 26 1 0
30 27 2 0
31 28 2 0
32 30 1 0
31 25 1 0
32 29 2 0
3 9 1 0
19 21 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 434.51Molecular Weight (Monoisotopic): 434.2006AlogP: 3.62#Rotatable Bonds: 8Polar Surface Area: 53.01Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.62CX LogP: 4.54CX LogD: 4.48Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -1.34
References 1. Fleischer R, Wiese M.. (2003) Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity., 46 (23): [PMID:14584949 ] [10.1021/jm030876r ] 2. Kaiser D, Terfloth L, Kopp S, Schulz J, de Laet R, Chiba P, Ecker GF, Gasteiger J.. (2007) Self-organizing maps for identification of new inhibitors of P-glycoprotein., 50 (7): [PMID:17352460 ] [10.1021/jm060604z ] 3. Jabeen I, Pleban K, Rinner U, Chiba P, Ecker GF.. (2012) Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein., 55 (7): [PMID:22452412 ] [10.1021/jm201705f ]